Blue Ox Healthcare Partners

Epic Sciences, Inc. is a diagnostics company based in San Diego, California, focused on improving cancer management through the development of highly sensitive tests that identify and characterize circulating tumor cells (CTCs) using minimally invasive blood samples. Founded in 2008, the company’s platform enables the profiling of single-cell phenotypes and genotypes, providing detailed information on biomarker expression levels, morphologic characteristics, and genetic changes. Epic Sciences offers the Oncotype DX AR-V7 Nucleus Detect test specifically for patients with metastatic castration-resistant prostate cancer, as well as biopharma solutions. The company collaborates with biotechnology and pharmaceutical firms, major cancer centers, and renowned research institutions, including the National Cancer Institute and the National Institutes of Health, to enhance personalized medicine and guide treatment decisions.

Gemelli Biotech is a biotechnology company based in North Carolina that focuses on the human microbiome and diagnostics for irritable bowel syndrome (IBS). Founded in 2018, the company aims to enhance health outcomes by unlocking the potential of the microbiome through innovative diagnostics and therapeutics. Gemelli Biotech develops medical devices that utilize blood tests to assess elevated levels of specific antibodies associated with post-infectious irritable bowel syndrome. Additionally, it offers a breath test system designed to identify small intestinal bacterial overgrowth, thereby providing physicians with optimized diagnostic protocols for various IBS types. The company is committed to bringing its biotechnology innovations to market in a socially responsible and fiscally prudent manner.

Epic Sciences, Inc. is a diagnostics company based in San Diego, California, focused on improving cancer management through the development of highly sensitive tests that identify and characterize circulating tumor cells (CTCs) using minimally invasive blood samples. Founded in 2008, the company’s platform enables the profiling of single-cell phenotypes and genotypes, providing detailed information on biomarker expression levels, morphologic characteristics, and genetic changes. Epic Sciences offers the Oncotype DX AR-V7 Nucleus Detect test specifically for patients with metastatic castration-resistant prostate cancer, as well as biopharma solutions. The company collaborates with biotechnology and pharmaceutical firms, major cancer centers, and renowned research institutions, including the National Cancer Institute and the National Institutes of Health, to enhance personalized medicine and guide treatment decisions.

Sera Prognostics, Inc. is a biotechnology company based in Salt Lake City, Utah, specializing in women's health diagnostics. Founded in 2008, it focuses on developing innovative diagnostic tests that aid in the early prediction of a woman's individualized risk for complications during pregnancy, including premature birth, preeclampsia, and gestational diabetes. Sera's proprietary proteomics and bioinformatics platform enables the discovery and commercialization of blood-based biomarker tests, which provide critical information to healthcare providers. Notably, the company's PreTRM® Test assesses the risk of spontaneous premature delivery, facilitating timely interventions for at-risk patients. By addressing the healthcare challenges associated with pregnancy complications, Sera aims to enhance maternal and neonatal health while reducing overall healthcare costs.

Sera Prognostics, Inc. is a biotechnology company based in Salt Lake City, Utah, specializing in women's health diagnostics. Founded in 2008, it focuses on developing innovative diagnostic tests that aid in the early prediction of a woman's individualized risk for complications during pregnancy, including premature birth, preeclampsia, and gestational diabetes. Sera's proprietary proteomics and bioinformatics platform enables the discovery and commercialization of blood-based biomarker tests, which provide critical information to healthcare providers. Notably, the company's PreTRM® Test assesses the risk of spontaneous premature delivery, facilitating timely interventions for at-risk patients. By addressing the healthcare challenges associated with pregnancy complications, Sera aims to enhance maternal and neonatal health while reducing overall healthcare costs.

Epic Sciences, Inc. is a diagnostics company based in San Diego, California, focused on improving cancer management through the development of highly sensitive tests that identify and characterize circulating tumor cells (CTCs) using minimally invasive blood samples. Founded in 2008, the company’s platform enables the profiling of single-cell phenotypes and genotypes, providing detailed information on biomarker expression levels, morphologic characteristics, and genetic changes. Epic Sciences offers the Oncotype DX AR-V7 Nucleus Detect test specifically for patients with metastatic castration-resistant prostate cancer, as well as biopharma solutions. The company collaborates with biotechnology and pharmaceutical firms, major cancer centers, and renowned research institutions, including the National Cancer Institute and the National Institutes of Health, to enhance personalized medicine and guide treatment decisions.

RX Solutions LLC, based in Boynton Beach, Florida, specializes in medical prescription assistance services. The company helps lower-income individuals access fixed or reduced-cost prescription drugs through its medication assistance programs, which cover a range of medications including Trulicity, Victoza, and ProAir. RX Solutions identifies suitable Prescription Assistance Programs (PAPs) for consumers based on their specific medication needs and guides them through the process to secure subsidies and obtain their medications.

Infinity Behavioral Health Services, LLC is a Fort Lauderdale, Florida-based company that specializes in providing comprehensive billing and consulting services for behavioral health facilities engaged in substance abuse and mental health treatment. Established in 2011, the company offers a range of solutions, including electronic claim submissions, claim scrubbing software, and detailed billing with appropriate coding. It also manages follow-up on unpaid claims, negotiates single-case agreements and in-network contracts, and provides customized reporting services. Additionally, Infinity delivers consulting on various operational aspects, such as admissions processes, documentation templates, and care guidelines. The company's expertise extends to assisting clients with clinical documentation, program scheduling, and eligibility verification, ensuring that behavioral health providers can focus on patient care while maximizing their insurance revenue.

PatientMatters is a provider of comprehensive patient receivables solutions designed to enhance financial outcomes for hospitals while improving patient experiences. The company focuses on seven critical areas of cash leakage, including pre-registration, emergency room processes, point-of-service collections, patient advocacy, early-out programs, payment plans, and bad debt management. Through its innovative platform, PatientMatters integrates patient registration, bill estimation, and financial services with intelligent workflows, enabling hospitals to streamline operations and increase revenue realization. By leveraging unique data sets, the company facilitates educational and engagement initiatives that not only boost cash collections but also foster stronger relationships between patients and healthcare providers, aligning incentives for all parties involved.